MoneyWorks4Me

The March 2025 quarter revenue stood at Rs. 9013.40 millions, up 11.39% as compared to Rs. 8092.00 millions during the corresponding quarter last year.A humble growth in net profit of 19.03% reported in the quarter ended March 2025 to Rs. 1498.00  millions from Rs. 1258.50 millions.Operating profit for the quarter ended March 2025 rose to 2445.10 millions as compared to 2111.50 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 9013.40 8092.00 11.39 37229.20 32986.40 12.86 37229.20 32986.40 12.86
Other Income 135.30 161.00 -15.96 347.40 346.80 0.17 347.40 346.80 0.17
PBIDT 2445.10 2111.50 15.80 10526.80 9141.00 15.16 10526.80 9141.00 15.16
Interest 9.30 83.20 -88.82 91.20 405.20 -77.49 91.20 405.20 -77.49
PBDT 2435.80 2028.30 20.09 10435.60 8735.80 19.46 10435.60 8735.80 19.46
Depreciation 444.10 397.20 11.81 1664.50 1352.40 23.08 1664.50 1352.40 23.08
PBT 1991.70 1631.10 22.11 8771.10 7383.40 18.79 8771.10 7383.40 18.79
TAX 493.70 372.60 32.50 2245.70 1949.80 15.18 2245.70 1949.80 15.18
Deferred Tax 57.80 93.40 -38.12 328.80 494.90 -33.56 328.80 494.90 -33.56
PAT 1498.00 1258.50 19.03 6525.40 5433.60 20.09 6525.40 5433.60 20.09
Equity 155.70 155.20 0.32 155.70 155.20 0.32 155.70 155.20 0.32
PBIDTM(%) 27.13 26.09 3.96 28.28 27.71 2.04 28.28 27.71 2.04
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..